MESENCHYMAL STEM (STROMAL) CELLS: PRECLINICAL EVIDENCE FOR POTENTIAL VALUE FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME

被引：0
|
作者：
Matthay, Michael A. [1 ]
机构：
[1] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA
来源：
SHOCK | 2017年 / 47卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
40
引用
收藏
页码：24 / 25
页数：2
相关论文
共 50 条
  • [31] Mesenchymal stem cells-derived extracellular vesicles in acute respiratory distress syndrome: a review of current literature and potential future treatment options
    Shah, Trushil G.
    Predescu, Dan
    Predescu, Sanda
    CLINICAL AND TRANSLATIONAL MEDICINE, 2019, 8 (01):
  • [32] Understanding the Role of Mesenchymal Stromal Cells in Treating COVID-19 Acute Respiratory Distress Syndrome
    O'Kane, Cecilia M.
    Matthay, Michael A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207 (03) : 231 - 233
  • [33] Enhancing the Efficacy of Mesenchymal Stromal Cells in COVID-19-related Acute Respiratory Distress Syndrome
    Zhang, Haibo
    Slutsky, Arthur S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (03) : 222 - 224
  • [34] Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome
    Kathleen D Liu
    Jennifer G Wilson
    Hanjing Zhuo
    Lizette Caballero
    Melanie L McMillan
    Xiaohui Fang
    Katherine Cosgrove
    Carolyn S Calfee
    Jae-Woo Lee
    Kirsten N Kangelaris
    Jeffrey E Gotts
    Angela J Rogers
    Joseph E Levitt
    Jeanine P Wiener-Kronish
    Kevin L Delucchi
    Andrew D Leavitt
    David H McKenna
    B Taylor Thompson
    Michael A Matthay
    Annals of Intensive Care, 4
  • [35] Mesenchymal Stromal Cells in Acute Respiratory Distress Syndrome: Shoulder Heavy Responsibilities, and a Long Way to Go
    Zhu, Feng
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209 (10) : 1276 - 1276
  • [36] Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome
    Liu, Kathleen D.
    Wilson, Jennifer G.
    Zhuo, Hanjing
    Caballero, Lizette
    McMillan, Melanie L.
    Fang, Xiaohui
    Cosgrove, Katherine
    Calfee, Carolyn S.
    Lee, Jae-Woo
    Kangelaris, Kirsten N.
    Gotts, Jeffrey E.
    Rogers, Angela J.
    Levitt, Joseph E.
    Wiener-Kronish, Jeanine P.
    Delucchi, Kevin L.
    Leavitt, Andrew D.
    McKenna, David H.
    Thompson, B. Taylor
    Matthay, Michael A.
    ANNALS OF INTENSIVE CARE, 2014, 4 : 1 - 9
  • [37] The promise of mesenchymal stem cell therapy for acute respiratory distress syndrome
    Antebi, Ben
    Mohammadipoor, Arezoo
    Batchinsky, Andriy I.
    Cancio, Leopoldo C.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2018, 84 (01): : 183 - 191
  • [38] Prevention of LPS-induced acute respiratory distress syndrome in sheep by bone marrow-derived mesenchymal stem/stromal cells
    Chaleshtori, Sirous Sadeghian
    Dezfouli, Mohammad Reza Mokhber
    Abbasi, Javad
    Dehghan, Mohammad Mehdi
    Fakhr, Massoumeh Jabbari
    Yadollahi, Shokufeh
    Mirabad, Mohammad Mehdi
    LIFE SCIENCES, 2020, 263
  • [39] Mesenchymal stem cells for acute lung injury: Preclinical evidence
    Matthay, Michael A.
    Goolaerts, Arnaud
    Howard, James P.
    Lee, Jae Woo
    CRITICAL CARE MEDICINE, 2010, 38 : S569 - S573
  • [40] Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review
    Sadeghi, Behnam
    Ringden, Olle
    Gustafsson, Britt
    Castegren, Markus
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345